As part of standard of care, 49% of patients received SGLT2i at some point during the trial
Interestingly, his recent work on the dietary supplement Immunocal, shows it to be a potential option for mitigating the deleterious effects of traumatic brain injuries (TBIs), such as concussion, and diseases like ALS
(A) IPGTT
All three medications Wegovy, Mounjaro, and Zepbound have been approved by the FDA to aid in weight loss
These include: Orlistat : A lipase inhibitor that reduces fat absorption, with a different mechanism and side effect profile than appetite suppressants Naltrexone-bupropion : A combination medication affecting reward pathways and appetite regulation Phentermine-topiramate ER (Qsymia) : An FDA-approved combination that has been studied more extensively than phentermine-semaglutide and is approved for long-term use Tirzepatide (Zepbound) : A dual GIP/GLP-1 receptor agonist that has demonstrated greater weight loss than semaglutide in head-to-head clinical trials (SURMOUNT-5) Intensive lifestyle interventions remain foundational to successful weight management
Blue Cross Blue Shield plans cover some weight loss medications, yet real-world patients frequently encounter barriers including prior authorization requirements, step therapy protocols, and coverage exclusions
